Q: Own VET, down 35% a pure gas/oil producer.
Own SU you describe as a TOTAL Energy investment.
Should I sell my VET at 35% loss and buy SU or add new money to VET and earn 8.15% on it, Raymond James forecast VET 12 month target at 41.00 ???
Your educated guess?
Art
Q: NPI ended the day on Mar. 19: Last: $23.36 C, Change: -2.38 -9.25 %.
First, can you explain this price decline? Second, would you say this stock is a screaming BUY at this price?
Q: Peter, I have held Kew for a period of six weeks or so and have seen the stock climb by 25% or so in that time. TD Bank has an action list buy on the stock and a very high one year price target. Is this one of those winners that you would hold on to?
Q: Celgene appears to be stumbling higher, presumably towards the value assigned to it from the Bristol Myers merger. In past months, you previously suggested holding on; is that still your view? Also, can you suggest a source for information on the tax treatment from the merger for Canadian taxpayers who hold Celgene? Thanks,
Q: Hi 5i. To further transfer from Balanced to Income portfolio, please pick from my top gainers and % gain from which to reduce or sell outright in order from 1st to last or leave alone.
XHC75%, VUN60%, ATD.B35%, ZUH30%, XEF25%, VXC25%, IYT25%.
The proceeds will then be used to top up your income port. and global div. players on pullbacks or as required. Does this make sense? What % cash should I keep in reserve? Thanks
Q: I currently own Slate Office Reit which has not been performing very well and was thinking of selling it and buying Summit industrial income Reit. I am interested in yield and growth and would appreciate your comments on this switch. Also I would appreciate your reasons for your suggestions. Thank you for all you do. Ian
Q: I just read Phil Town's "Rule #1" where he argues, amongst other things that return on equity (aka book value), sales growth, EPS growth, Cash flow and ROIC are the strongest indicators for long term growth. He argues that, ideally we'd invest in companies that have at least 10% growth in each category for each of the past 10 years - a lofty goal to be sure.
Generally, how do you feel about the aforementioned metrics to assess the quality of an invesment. Would you keep them in the same order of priority and would you add any to the mix?
For the record, the only stock I can find that comes close to meeting the 10% increase per year threshold is CSU so maybe there's something to it!
Q: Any idea why TH has been so weak lately. I know sales have been short of expectations for their new life saving drug but they are still rising slowly. Also their older drug Egrifta may have some benefits for people with NAFLD/NASH. Balance sheet is good.
Q: Good morning. I've been riding this loser CHE.UN for some time and have noted your previous comments on same. I think I should sell now and take my lumps. Where should I reinvest in this sector, with dividends and potential for growth. Thanks
Q: In this month's MoneySaver magazine, there is an article by Rita Silvan titled "Spin-offs, Ticker Symbols and Other Investment Anomalies". In this article, she states that in the last 15 years, from 2002 to 2017, the Bloomberg US Spun-Off Index returned nearly 1,000% compared to the S&P 500 Index which returned 203.9%.
Are you aware of any ETFs which track this index? What is your view about ETFs which track spin-offs? Is this a strategy which you would recommend? I could only find the Invesco S&P Spin-Off ETF (CSD) and its returns appear to be 2.15% annually over the last 5 years, and is a significant underperformer compared to the S&P500.
Thank you again for your invaluable advice. This service is truly excellent!
Q: Further to my question about undervalued Canadian dividend paying "blue chip" equity, what do you think of Canadian Tire?
1. Does it fit the above criteria, if not why
2.Present value, is P/E the right way of assessing
3.Immediate risk of further decline for CTC specifically or its' sector